• Exchange: New York
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Generic Pharma

ACT:US

224.7300 USD 2.6600 1.20%

As of 20:04:03 ET on 10/17/2014.

Snapshot for Actavis plc (ACT)

Open: 224.2800 Day's Range: 222.3200 - 229.9800 Volume: 2,345,332
Previous Close: 222.0700 52wk Range: 143.7100 - 249.9400 1-Yr Rtn: +52.96%

Stock Chart for ACT

No chart data available.
  • ACT:US 224.7300
  • 1D
  • 1M
  • 1Y
222.0700
Interactive ACT Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for ACT

Current P/E Ratio (ttm) 31.9934
Estimated P/E(12/2014) 16.9110
Relative P/E vs. SPX 1.8884
Earnings Per Share (USD) (ttm) 7.0243
Est. EPS (USD) (12/2014) 13.2890
Est. PEG Ratio 0.9942
Market Cap (M USD) 59,387.31
Shares Outstanding (M) 264.26
30 Day Average Volume 2,627,851
Price/Book (mrq) 4.0443
Price/Sale (ttm) 3.6364
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 11/05/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for ACT

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for ACT

Actavis plc manufactures specialty pharmaceuticals. The Company develops, manufactures and distributes generic, brand and over-the-counter products. Actavis offers its pharmaceutical drugs around the world.

Paul M BisaroChairmanBrenton L Saunders "Brent"President/CEO
R Todd JoyceChief Financial OfficerRobert A Stewart "Bob"Chief Operating Officer
More Company Profile & Key Executives for ACT

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil